According to KemPharm's latest financial reports the company's current revenue (TTM) is S$13.62 M. In 2021 the company made a revenue of S$38.63 M an increase over the revenue in the year 2020 that were of S$17.56 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.